- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Directors of Gufic Biosciences Limited has addressed the fine levied by the National Stock Exchange regarding an alleged non-compliance related to the appointment of Mr. Kamal Kishore Seth as an Additional Director. The Board reviewed the communication from the Exchange and reaffirmed the Company's stance regarding the appointment, stating that there was no intent to engage in non-compliance. They believe the issue arose from differing interpretations of regulatory provisions. This situation emphasizes Gufic's commitment to compliance and may present an opportunity for enhanced governance clarity moving forward. Investors should watch closely for any further developments related to this issue.